ASAH2 and malignant colon neoplasm: Inhibition of ASAH2 decreased active (phosphorylated) AKT pool and induced dephosphorylation of GSK3β, which was then followed by phosphorylation and degradation of β-catenin and suppression of proliferation of colon cancer cells, both in vitro and in vivo [19].